Preventive Healthcare Technologies, Products and Markets

Preventive Healthcare Technologies, Products and Markets

Forecasts for the U.S. market in products and services, providing data for 2008 and estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014, and 2014 to 2019
An overview of preventive healthcare functions, including early detection, prophylaxis, prevention of errors in therapy, and chronic care management
A breakdown of the market for early detection and screening products, including prenatal and neonatal tests, pediatric tests, and adult tests for both sexes
Detailed company profiles and a patent analysis.

Chapter- 1: INTRODUCTION -- Complimentary

STUDY BACKGROUND 1
GOALS AND OBJECTIVES 2
INTENDED AUDIENCE 2
SCOPE OF REPORT 3
METHODOLOGY 4
AUTHOR’S CREDENTIALS 4
RELATED BCC REPORTS 5
BCC ONLINE SERVICES 5
DISCLAIMER 6

Chapter-2: SUMMARY

SUMMARY TABLE U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES, THROUGH 2014 ($ MILLIONS) 7
SUMMARY FIGURE U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES, 2008-2014 ($ MILLIONS) 8

Chapter-3: OVERVIEW OF PREVENTIVE HEALTHCARE

DEFINITIONS 9
PREVENTIVE HEALTHCARE FUNCTIONS 9
EARLY DETECTION 9
TABLE 1 U.S. AGENCY FOR HEALTHCARE RESEARCH AND QUALITY RECOMMENDED SCREENING PROCEDURES 10
Personalized Screening 11
Automated Screening 12
Other New Screening Technologies 12
PROPHYLAXIS 12
PREVENTION OF ERRORS, ADVERSE EFFECTS, AND COMPLICATIONS FROM MEDICAL TREATMENT 13
CHRONIC DISEASE MANAGEMENT 14
ENABLING TECHNOLOGIES 15
GENOMICS/PROTEOMICS/CYTOMICS 15
Genomics 15
Genomics (Continued) 16
Proteomics 17
Cytomics 18
NANOTECHNOLOGY 18
Nanomaterials 19
Nanodevices 20
INFORMATION TECHNOLOGIES 21
Electronic Prescribing Systems 21
Clinical Decision Support Systems 21
AUTOMATION 22
Wireless Technologies 22
Sensors 23
Robotics 24
Artificial Intelligence and Decision Support 24
TABLE 2 APPLICATIONS OF ARTIFICIAL INTELLIGENCE TO PREVENTIVE HEALTHCARE 25
RFID/Barcoding 25
END USER SEGMENTS 26
HOSPITALS 26
PHYSICIAN PRACTICES 27
LONG-TERM CARE FACILITIES 27
MILITARY 27
HEALTH INSURERS 28
EMPLOYERS 29
CONSUMERS 29
FIGURE 1 PROJECTED U.S. POPULATION, 2008–2019 (MILLIONS) 30
Persons Requiring Screening and Early Detection Services 30
Persons Requiring Prophylaxis 31
TABLE 3 TARGET GROUPS FOR SELECTED VACCINES, 2008 (MILLIONS) 31
Persons with Chronic Illness 31
Hypertension 32
Diabetes 32
High Cholesterol Levels 33
Heart Disease 34
Asthma 34
MARKET SUMMARY 35
TABLE 4 U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES BY FUNCTION, THROUGH 2014 ($ MILLIONS) 35
FIGURE 2 U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES MARKET SHARES BY FUNCTION, 2008–2014 (%) 36

Chapter-4: MARKET ENVIRONMENT FOR PREVENTIVE HEALTHCARE

FEDERAL GOVERNMENT INITIATIVES 37
CENTERS FOR MEDICARE AND MEDICAID SERVICES 37
Medicare 37
Medicaid 38
SCHIP 38
OTHER FEDERAL PREVENTIVE-CARE PROGRAMS 39
Immunization Grant (Section 317) Program 39
National Breast and Cervical Cancer Early Detection Program 39
PROPOSED U.S. HEALTHCARE SYSTEM RESTRUCTURING 40
RELATED FEDERAL INITIATIVES 41
ETHICAL CONCERNS 42

Chapter-5: TRENDS IN THE HEALTHCARE INDUSTRY

RISING HEALTHCARE COSTS 43
FIGURE 3 TOTAL U.S. HEALTHCARE EXPENDITURES, 1968–2008 ($ BILLIONS IN 2008 DOLLARS) 43
FIGURE 4 PER-CAPITA U.S. HEALTHCARE EXPENDITURES, 1968–2008 ($ BILLIONS IN 2008 DOLLARS) 44
FIGURE 5 U.S. HEALTHCARE EXPENDITURES AS A PERCENTAGE OF REAL GDP, 1968 AND 2008 (2008 $ BILLIONS) 45
PREVENTIVE HEALTHCARE AND OVERALL MEDICAL EXPENDITURES 45
FIGURE 6 U.S. EXPENDITURES ON PREVENTIVE VS. OTHER TYPES OF HEALTHCARE, 2008 ($ BILLIONS) 46
PREVENTIVE HEALTHCARE … (CONTINUED) 47
HEALTH INSURANCE COVERAGE AND REIMBURSEMENT 48
MEDICAL EDUCATION 49
HEALTHCARE PROFESSIONALS’ ATTITUDES 50
PATIENT ATTITUDES 51
ECONOMIC ENVIRONMENT 52
EMPLOYMENT TRENDS 52
FIGURE 7 TRENDS IN U.S. NON-FARM PAYROLL EMPLOYMENT (000 WORKERS) 53
IMPACT OF ECONOMIC TRENDS ON EMPLOYER HEALTH COVERAGE 54
FIGURE 8 TRENDS IN EMPLOYER-SPONSORED HEALTH INSURANCE, 2000–2008 (PERCENT OF U.S. COMPANIES OFFERING HEALTH INSURANCE) 54
FIGURE 8 (CONTINUED) 55

Chapter-6: EARLY DETECTION AND SCREENING: TECHNOLOGIES, PRODUCTS AND MARKETS, 2008–2014

SUMMARY 56
FIGURE 9 U.S. MARKET FOR ADVANCED HEALTH SCREENING AND EARLY DETECTON TECHNOLOGIES, 2008–2014 ($ MILLIONS) 56
TECHNOLOGIES AND PRODUCTS 57
PERSONALIZED MEDICINE 57
Genetic Testing 57
Genetic Testing (Continued) 58
Suppliers of Genetic Tests 59
TABLE 5 SUPPLIERS OF GENETIC TESTS 59
Proteomic Tests 59
Proteomic Tests (Continued) 60
Suppliers of Proteomic Tests 61
TABLE 6 SUPPLIERS OF PROTEOMIC TESTS 61
AUTOMATED SCREENING 61
Telehealth Kiosks 61
Telehealth Kiosks (Continued) 62
Suppliers of Telehealth Kiosks 63
TABLE 7 SUPPLIERS OF TELEHEALTH KIOSKS 63
Eye Health Kiosks 63
Automated Drug Testing 64
Suppliers of Automated Drug Testing Equipment 65
TABLE 8 DEVELOPERS AND SUPPLIERS OF AUTOMATED DRUG TESTING EQUIPMENT 65
OTHER ADVANCED SCREENING TESTS 65
Breast Cancer Screening 65
Molecular Breast Imaging 65
Automated Whole Breast Ultrasound 66
CT Colonography 67
Automated Skin Cancer Screening 68
Suppliers 69
TABLE 9 DEVELOPERS AND SUPPLIERS OF OTHER ADVANCED HEALTH SCREENING TECHNOLOGIES 69
MARKETS 69
SUMMARY 69
TABLE 10 U.S. MARKET FOR ADVANCED HEALTH SCREENING AND EARLY DETECTION TECHNOLOGIES, THROUGH 2014 ($ MILLIONS) 70
FIGURE 10 EARLY DETECTION AND SCREENING PRODUCT SEGMENTS, 2008-2014 (%) 70
FIGURE 10 (CONTINUED) 71
PERSONALIZED MEDICINE 71
TABLE 11 U.S. MARKET FOR PERSONALIZED PREVENTIVE MEDICINE ($ MILLIONS) 71
Genetic Screening 71
FIGURE 11 U.S. GENETIC TESTING MARKET SHARES, 2008 (%) 72
TABLE 12 U.S. MARKET FOR GENETIC SCREENING TESTS ($ MILLIONS) 73
Proteomic Screening 73
TABLE 13 U.S. MARKET FOR PROTEOMIC SCREENING TESTS ($ MILLIONS) 73
AUTOMATED SCREENING 74
TABLE 14 U.S. MARKET FOR AUTOMATED HEALTH ASSESSMENT AND SCREENING SYSTEMS BY TYPE OF SYSTEM, THROUGH 2014 ($ MILLIONS) 74
Telehealth Kiosks 74
TABLE 15 NEW TELEHEALTH KIOSK SALES AND LEASE REVENUES, 2014 (UNITS/$) 75
Eye Health Kiosks 75
TABLE 16 U.S. MARKET FOR AUTOMATED EYE HEALTH KIOSKS, THROUGH 2014 ($ MILLIONS) 75
Automated Drug Testing 76
FIGURE 12 AUTOMATED TEST EQUIPMENT SHARE OF DRUG TESTING MARKET, 2008 (%) 76
FIGURE 13 DRUGS OF ABUSE VS. THERAPEUTIC DRUG TESTING SHARES OF AUTOMATED DRUG TESTING EQUIPMENT MARKET, 2008 (%) 77
TABLE 17 U.S. MARKET FOR AUTOMATED DRUG TESTING SYSTEMS, THROUGH 2014 ($ MILLIONS) 78
OTHER ADVANCED SCREENING AND EARLY DETECTION TECHNOLOGIES 78
TABLE 18 U.S. MARKET FOR OTHER ADVANCED SCREENING TECHNOLOGIES BY TYPE OF SYSTEM, THROUGH 2014 ($ MILLIONS) 79
BREAST CANCER SCREENING 79
TABLE 19 U.S. MARKET FOR ADVANCED BREAST CANCER SCREENING SYSTEMS, THROUGH 2014 ($ MILLIONS) 79
Molecular Breast Imaging 80
TABLE 20 U.S. MARKET FOR MOLECULAR BREAST IMAGING SYSTEMS, THROUGH 2014 ($ MILLIONS) 80
ABUS 80
TABLE 21 U.S. MARKET FOR AUTOMATED WHOLE BREAST ULTRASOUND SYSTEMS, THROUGH 2014 ($ MILLIONS) 81
CT COLONOGRAPHY 81
TABLE 22 U.S. MARKET FOR CT COLONOGRAPHY, THROUGH 2014 ($ MILLIONS) 81
AUTOMATED SKIN CANCER DETECTION 82
TABLE 23 U.S. MARKET FOR AUTOMATED SKIN CANCER DETECTION SYSTEMS, THROUGH 2014 ($ MILLIONS) 82

Chapter-7: PROPHYLAXIS: TECHNOLOGIES, PRODUCTS AND MARKETS

SUMMARY 83
FIGURE 14 U.S. MARKET FOR NEW VACCINES, 2008–2014 ($ MILLIONS) 83
TECHNOLOGIES 84
FLU VACCINES 84
Bird Flu Vaccine 85
Swine Flu Vaccine 85
MENINGOCOCCAL VACCINES 85
COMBINED TETANUS-DIPHTHERIA-PERTUSSIS VACCINES 86
HUMAN PAPILLOMA VIRUS VACCINE 87
OTHER NEW VACCINES 88
MMR/Varicella Vaccine 88
Rotavirus Vaccines 89
Shingles Vaccine 89
MARKETS 90
SUMMARY 90
FIGURE 15 U.S. MARKET FOR NEW HUMAN VACCINES, 2008 (%) 90
FIGURE 15 (CONTINUED) 91
TABLE 24 U.S. MARKET FOR NEW VACCINES, THROUGH 2014 ($ MILLIONS) 91
FLU VACCINES 91
TABLE 25 U.S. PURCHASES OF NOVEL FLU VACCINES, THROUGH 2014 ($ MILLIONS) 92
MENINGOCOCCAL VACCINES 92
TABLE 26 U.S. MARKET FOR MENINGOCOCCAL VACCINES, THROUGH 2014 ($ MILLIONS) 92
TDAP VACCINES 93
TABLE 27 U.S. MARKET FOR TDAP VACCINES, THROUGH 2014 ($ MILLIONS) 93
HPV VACCINES 93
TABLE 28 U.S. MARKET FOR HPV VACCINES, THROUGH 2014 ($ MILLIONS) 94
OTHER NEW VACCINES 94
MMR/Varicella 94
TABLE 29 U.S. MARKET FOR OTHER NEW VACCINES, THROUGH 2014 ($ MILLIONS) 95
Rotavirus 95
Shingles 95

Chapter-8: PREVENTING THERAPEUTIC ERRORS AND FAILURES: TECHNOLOGIES, PRODUCTS AND MARKETS

SUMMARY 96
FIGURE 16 U.S. MARKET FOR THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES PROJECT SHARES, 2008–2014 ($ MILLIONS) 96
TECHNOLOGIES 97
CLINICAL DECISION AIDS AND OTHER INFORMATION TECHNOLOGIES 97
Electronic Prescribing 97
Software 97
Software (Continued) 98
Software (Continued) 99
Mobile Interface Devices 100
Electronic Data Interchange 100
TABLE 30 E-PRESCRIPTION SOFTWARE VENDORS 101
Computerized Provider Order Entry Systems 101
Computerized Provider … (Continued) 102
TABLE 31 CPOE TECHNOLOGY VENDORS 103
Clinical Decision Support Systems 103
TABLE 32 CLINICAL DECISION SUPPORT TECHNOLOGY VENDORS 104
MEDICATION FORMULATION, DISPENSING, AND PACKAGING SYSTEMS 104
Automated Prescription Formulation/Dispensing Systems 105
Packaging Machines 105
Tablet Counters 105
Unit-Dose or Blister Pack Repackaging and Dispensing Systems 105
Intravenous Compounders 106
Dispensing Systems 106
Centralized Dispensing Systems 106
Automated Medication Carts 106
Decentralized Dispensing Devices 106
Smart Infusion Pumps 107
TABLE 33 SUPPLIERS OF AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING SYSTEMS 108
Packaging 108
Bottle Cap Medication Reminder 109
Medication Label Reader for the Visually Impaired 109
MARKETS 110
SUMMARY 110
TABLE 34 U.S. MARKET FOR THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES, THROUGH 2014 ($ MILLIONS) 110
FIGURE 17 THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES PROJECT SHARES, 2008–2014 (%) 111
ELECTRONIC PRESCRIBING 111
TABLE 35 U.S. MARKET FOR ELECTRONIC PRESCRIBING TECHNOLOGIES, THROUGH 2014 ($ MILLIONS) 112
FIGURE 18 U.S. ELECTRONIC PRESCRIPTION MARKET SEGMENTS (%) 113
COMPUTERIZED PROVIDER ORDER ENTRY 113
TABLE 36 NUMBER OF U.S. HOSPITALS WITH COMPUTERIZED PROVIDER ORDER ENTRY SYSTEMS, THROUGH 2007 114
TABLE 37 U.S. MARKET FOR COMPUTERIZED PROVIDER ORDER ENTRY SYSTEMS, THROUGH 2014 ($ MILLIONS) 114
COMPUTERIZED DECISION SUPPORT 114
TABLE 38 U.S. MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS, THROUGH 2014 ($ MILLIONS) 115
AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING 115
TABLE 39 U.S. MARKET FOR HOSPITAL/INPATIENT AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING SYSTEMS, THROUGH 2014 ($ MILLIONS) 115
SMART INFUSION PUMPS 115
TABLE 40 U.S. MARKET FOR SMART INFUSION PUMPS, THROUGH 2014 ($ MILLIONS) 116
SMART PACKAGING 116
TABLE 41 U.S. MARKET FOR SMART PACKAGING TO PREVENT MEDICATION ERRORS, THROUGH 2014 ($ MILLIONS) 116
Smart Packaging (Continued) 117

Chapter-9: CHRONIC DISEASE MANAGEMENT: TECHNOLOGIES, PRODUCTS AND MARKETS

SUMMARY 118
FIGURE 19 U.S. MARKET FOR ADVANCED CHRONIC DISEASE MANAGEMENT TECHNOLOGIES AND SERVICES, 2008-2014 ($ MILLIONS) 118
TECHNOLOGIES 119
MONITORING 119
Blood Pressure Monitors 119
Blood Pressure Monitors (Continued) 120
Glucose Monitors 120
Glucose Monitors (Continued) 121
Cholesterol Monitors 122
Cardiac Monitors 122
Asthma Monitors 123
Pervasive Monitoring 123
Embedded Monitors 124
Wearable Monitors 124
Wireless Telemetry 125
Cellular Networks 126
Bluetooth 126
Other Technologies 126
Suppliers 127
TABLE 42 SUPPLIERS OF ADVANCED TECHNOLOGIES FOR MONITORING CHRONIC DISEASES 127
THERAPEUTIC DEVICES 127
Insulin Administration Devices 128
Insulin Pumps 128
Insulin Inhalers 129
Suppliers 130
TABLE 43 SUPPLIERS OF ADVANCED THERAPEUTIC DEVICES FOR CHRONIC DISEASES 130
COMMERCIAL CHRONIC DISEASE MANAGEMENT SERVICES 130
Commercial Chronic Disease … (Continued) 131
Suppliers 132
TABLE 44 CHRONIC DISEASE MANAGEMENT ORGANIZATIONS 132
MARKETS 132
SUMMARY 132
TABLE 45 MARKET FOR CHRONIC DISEASE MANAGEMENT TECHNOLOGIES, THROUGH 2014 ($ MILLIONS) 133
FIGURE 20 CHRONIC DISEASE MANAGEMENT TECHNOLOGIES AND SERVICES MARKET SHARES, 2008-2014 (%) 133
FIGURE 20 (CONTINUED) 134
MONITORING 134
TABLE 46 MARKET FOR ADVANCED MONITORING TECHNOLOGIES FOR CHRONIC DISEASE MANAGEMENT, THROUGH 2014 ($ MILLIONS) 134
Advanced Sensors 134
TABLE 47 U.S. MARKET FOR ADVANCED NONINVASIVE SENSORS, THROUGH 2014 ($ MILLIONS) 135
Pervasive Monitoring 135
TABLE 48 HOME MONITORING AND TELEMETRY SALES, THROUGH 2014 ($ MILLIONS) 135
Telemetry 136
TABLE 49 SALES OF HOME TELEMETRY MONITORS, THROUGH 2014 ($ MILLIONS) 136
THERAPEUTIC DEVICES 136
TABLE 50 MARKET FOR ADVANCED THERAPEUTIC DEVICES FOR CHRONIC DISEASE MANAGEMENT, THROUGH 2014 ($ MILLIONS) 137
Insulin Pumps 137
TABLE 51 MARKET FOR INSULIN PUMPS, THROUGH 2014 ($ MILLIONS) 137
TABLE 52 INSULIN PUMP SALES, THROUGH 2014 (NUMBER OF PUMPS/$ MILLION) 138
Insulin Inhalers 138
TABLE 53 MARKET FOR INSULIN INHALERS, THROUGH 2014 ($ MILLIONS) 138
DISEASE MANAGEMENT SERVICES 139
TABLE 54 MARKET FOR COMMERCIAL DM SERVICES, THROUGH 2014 ($ MILLIONS) 139

Chapter-10: APPENDIX

APPENDIX A: COMPANY PROFILES 140
EARLY DETECTION AND SCREENING 140
COMPUTERIZED SCREENING INC. 140
CORRELOGIC SYSTEMS, INC. 140
DILON TECHNOLOGIES 141
GAMMA MEDICA-IDEAS, INC. 141
ICAD INC. 141
MYRIAD GENETICS, INC. 142
NOVX SYSTEMS INC. 142
POLARTECHNICS LTD. 143
STREETIME TECHNOLOGIES 143
U-SYSTEMS, INC. 143
VERMILLION, INC. 144
VIATRONIX, INC. 145
PROPHYLAXIS 145
MERCK & CO., INC. 145
ERROR PREVENTION 146
BAXA CORP. 146
DRFIRST.COM 146
LIFECOM, INC. 146
MASSACHUSETTS GENERAL HOSPITAL 147
OMNICELL, INC. 147
SCRIPTPRO 148
SIGMA INTERNATIONAL GENERAL MEDICAL APPARATUS LLC 148
SURESCRIPTS LLC 149
THERADOC INC. 149
CHRONIC DISEASE MANAGEMENT 150
ALERE 150
CARD GUARD AG 150
ECHO THERAPEUTICS, INC. 151
HEALTH FRONTIER, INC. 151
HEALTHWAYS, INC. 152
MANNKIND CORP. 152
MEDTRONIC MINIMED INC. 152
MICRODOSE THERAPEUTX, INC. 153
OMRON HEALTHCARE, INC. 153
PFIZER INC. 153
PREMD INC. 154
T+ MEDICAL AMERICAS 154
U.S. PREVENTIVE MEDICINE 155
VECTURA GROUP PLC 156
VIVOMETRICS INC. 156
APPENDIX B: PATENT ANALYSIS 157
FIGURE 21 U.S. PATENTS RELATED TO NEW PREVENTIVE HEALTHCARE TECHNOLOGIES (%) 157